Janssen - Advanced prostate cancer: How do we move forward in patient management?
Flattening the curve: Consequences for the management of prostate cancer in the ongoing COVID-19 pandemic
Date
14 Sep 2020Session
Janssen - Advanced prostate cancer: How do we move forward in patient management?Presenters
Boris HadaschikAuthors
E. Efstathiou1, E. Castro Marcos2, K.N. Chi3, B.A. Hadaschik4Author affiliations
- 1 The M. D. Anderson Cancer Center, 77030 - Houston/US
- 2 CNIO - Centro Nacional de Investigaciones Oncologicas, 28029 - Madrid/ES
- 3 Medical Oncology Department, BC Cancer Agency - Vancouver, V5Z 4E6 - Vancouver/CA
- 4 Department Of Urology, University Hospital of Essen, 45147 - Essen/DE
Resources
Resources from the same session
Optimising care for individual patients with metastatic hormone sensitive prostate cancer
Presenter: Nicolas Mottet
Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?
Resources:
Webcast
Non metastatic castration resistant prostate cancer translating benefit to clinical practice & Choosing the right pathway in the current and future management of metastatic castration resistant prostate cancer
Presenter: Nicolas Mottet
Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?
Resources:
Webcast
Live Q&A - 18 September 2020 - 17:00-18:00
Presenter: Boris Hadaschik
Session: Janssen - Advanced prostate cancer: How do we move forward in patient management?
Resources:
Webcast